PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou… Mar 2, 2021
PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic… Feb 23, 2021
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine Feb 1, 2021
PharmaTher Signs Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and… Jan 19, 2021